Avivagen Inc.
OTC: VIVXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- G. F. Kym Anthony
- Employees
- 13
- Headquarters
- Ottawa, Canada
- IPO year
- 2013
- Market cap
- $7.8K
- Website
- https://www.avivagen.com
Loading VIVXF…
Loading profile data…Frequently asked questions about VIVXF
What does Avivagen Inc. (VIVXF) do?
Avivagen Inc. is a life sciences firm primarily engaged in creating and distributing specialized feed supplements for livestock. These products are designed to bolster animals' immune function and contribute to their enhanced growth and overall productivity. The company's diverse product portfolio includes OxC-beta Livestock, a key additive for...
Where does VIVXF trade?
Avivagen Inc. (VIVXF) trades on the Other OTC.
What sector is VIVXF in?
Avivagen Inc. (VIVXF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Avivagen Inc.?
G. F. Kym Anthony is the chief executive officer of Avivagen Inc. (VIVXF).
Where is Avivagen Inc. headquartered?
Avivagen Inc. is headquartered in Canada.
Does VIVXF pay a dividend?
Avivagen Inc. (VIVXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIVXF go public?
Avivagen Inc. (VIVXF) completed its initial public offering in 2013.